Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial

RATIONALE: Aside from blood pressure lowering, treatment options for intracerebral haemorrhage remain limited and a proportion of patients will undergo early haematoma expansion with resultant significant morbidity and mortality. Tranexamic acid (TXA), an anti-fibrinolytic drug, has been shown to si...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaherty, Katie, Bath, Philip M., Dineen, Robert, Law, Zhe, Scutt, Polly, Pocock, Stuart, Sprigg, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738041/
https://www.ncbi.nlm.nih.gov/pubmed/29262841
http://dx.doi.org/10.1186/s13063-017-2341-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738041/
https://www.ncbi.nlm.nih.gov/pubmed/29262841
http://dx.doi.org/10.1186/s13063-017-2341-5

Ejemplares similares